We are using cookies This website uses cookies in order to offer you the most relevant information. By browsing this website, you accept these cookies.
Disease diagnosed by a cluster of at least 3 out of the following conditions: abdominal obesity, high blood pressure, high blood sugar, high serum triglycerides, low serum high-density lipoprotein.
Many cardiovascular risk factors cluster within the insulinresistancesyndrome.
2
Background: Hypertension is often associated with multiple metabolic abnormalities included in the insulinresistancesyndrome.
3
We examined relationships between homocysteine levels and features of insulinresistancesyndrome (IRS).
4
Diagnostic criteria for the insulinresistancesyndrome, including clinical values for each risk factor, were developed.
5
The insulinresistancesyndrome (IRS) is considered to be a new target of risk-reduction therapy.
6
These observations offer a robust explanation for the positive effects of pravastatin treatment in patients with insulinresistancesyndrome.
7
The insulinresistancesyndrome has been noted as an interesting and important new risk factor for coronary artery disease.
8
These drugs can potentially decrease the risk of cardiovascular disease by correcting the different components of the insulinresistancesyndrome.
9
Objective: To examine associations of neighborhood characteristics with six components of the insulinresistancesyndrome (IRS) in young adults.
10
The insulinresistancesyndrome together with hyperinsulinemia is likely to induce atherosclerotic changes, possibly through reduced rather than excessive action of insulin.
11
We also determined the strength of the association of NASH with insulinresistancesyndrome (IRS) as defined by World Health Organization criteria.
12
An increased intracellular availability of the co-enzyme A esters of long-chain fatty acids is thought to underlie many aspects of the insulinresistancesyndrome.
13
Conclusions: A diet rich in high-viscosity KJM improves glycemic control and lipid profile, suggesting a therapeutic potential in the treatment of the insulinresistancesyndrome.
14
Endothelial dysfunction with impaired nitric oxide biosynthesis and decreased bioavailability has been implicated in insulinresistancesyndrome and Type II (non-insulin-dependent) diabetes mellitus.
15
We conclude that the TRP64ARG beta 3AR variant is a susceptibility gene for several features of the insulinresistancesyndrome in Mexican Americans.
16
Insulin resistance , the insulinresistancesyndrome and atherogenesis are all thought to involve endothelial dysfunction, though in different vascular beds.